Skip to content

Contact +44 (0) 20 7060 7474 email us

Healthcare

Genomic Health, Inc. - Financial and Strategic Analysis Review

 

Publication Date June 2009
Publisher Global Markets Direct
Product Type Report
Pages 17
ISBN Number not applicable
Product Code GMD02138

Price

£83.00
approximately: $126 | €93

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Genomic Health, Inc. - Financial and Strategic Analysis Review

Genomic Health, Inc. (Genomic Health) is a life science company principally engaged in conducting genomic research to develop and commercialize clinically approved molecular diagnostics and laboratory services for the treatment of cancer. These molecular diagnostic provides information, which is used by the healthcare professionals and patients in making decisions regarding treatment or therapy. The company is headquartered in California, United States. On Jan 07, 2008, the company entered into an agreement with Pfizer on the development of a genomic test to estimate the risk of recurrence following surgery for patients with Stage I-III renal carcinoma, clear cell type

Global Markets Direct's Genomic Health, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Genomic Health, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

  • Provides key company information for business intelligence needs.
  • The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
  • The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
  • The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
  • The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
  • Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

  • A quick "one-stop-shop" to understand the company.
  • Enhance business/sales activities by understanding customers' businesses better.
  • Get detailed information and financial and strategic analysis on companies operating in your industry.
  • Identify prospective partners and suppliers - with key data on their businesses and locations.
  • Capitalize on competitor's weaknesses and target the market opportunities available to them.
  • Compare your company's financial trends with those of your peers / competitors.
  • Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

  • List of Tables
  • List of Figures
    • Key Facts
    • Business Description
    • Major Products and Services
    • History
    • SWOT Analysis
    • SWOT Analysis - Overview
    • Genomic Health, Inc. - Strengths
    • Genomic Health, Inc. - Strengths - Sturdy Research and Development Activities
    • Genomic Health, Inc. - Strengths - Strong Revenue Growth
    • Genomic Health, Inc. - Strengths - Strong Liquidity Position
    • Genomic Health, Inc. - Weaknesses
    • Genomic Health, Inc. - Weaknesses - Dependence on Single Product
    • Genomic Health, Inc. - Weaknesses - Limited Geographic Presence
    • Genomic Health, Inc. - Opportunities
    • Genomic Health, Inc. - Opportunities - Growth in the Prevalence of Cancer
    • Genomic Health, Inc. - Opportunities - Rising Healthcare Expenditure in the US
    • Genomic Health, Inc. - Opportunities - Emerging Markets
    • Genomic Health, Inc. - Threats
    • Genomic Health, Inc. - Threats - Dependence on Limited Number of Payors
    • Genomic Health, Inc. - Threats - Tightening of FDA's Regulatory Oversight
    • Genomic Health, Inc. - Threats - Effect of Global Slowdown
    • Key Competitors
    • Key Employees
    • Key Employee Biographies
    • Company Statement
    • Locations And Subsidiaries
    • Locations And Subsidiaries - Head Office
    • Financial Ratios
    • Financial Ratios - Capital Market Ratios
    • Financial Ratios - Annual Ratios
    • Financial Ratios - Interim Ratios
    • Financial Ratios - Ratio Charts
  • Appendix
    • Methodology
    • Ratio Definitions
    • About Global Markets Direct
    • Contact Us
    • Disclaimer
  • List of Tables
    • Genomic Health, Inc., Key Facts
    • Major Products and Services
    • Genomic Health, Inc., History
    • Genomic Health, Inc., Key Employees
    • Genomic Health, Inc., Key Employee Biographies
    • Genomic Health, Inc., Ratios based on current share price
    • Genomic Health, Inc., Annual Ratios
    • Genomic Health, Inc., Interim Ratios
    • Currency Codes
    • Capital Market Ratios
    • Equity Ratios
    • Profitability Ratios
    • Cost Ratios
    • Liquidity Ratios
    • Leverage Ratios
    • Efficiency Ratios
  • List of Figures
    • Genomic Health, Inc., Ratio Charts
Product Features / Use
Scope Expert Insight/Opinion
Profiles In-depth Company Insight
Features Contains SWOT Analysis